Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults Journal Article uri icon

Overview

publication date

  • March 29, 2018

has subject area

has restriction

  • gold

Date in CU Experts

  • April 6, 2018 9:37 AM

Full Author List

  • Martens CR; Denman BA; Mazzo MR; Armstrong ML; Reisdorph N; McQueen MB; Chonchol M; Seals DR

author count

  • 8

citation count

  • 334

Other Profiles

Electronic International Standard Serial Number (EISSN)

  • 2041-1723

Additional Document Info

volume

  • 9

number

  • ARTN 1286